posted on 2016-03-01, 10:06authored byLinda Sharp, Cathal Dominic Walsh, Sophie Whyte, Lesley Tilson, Alan O'Ceilleachair, Cara Usher, Paul Tappenden, James Chilcott, Anthony Staines, Michael Barry, Harry Comber
In his letter, Dr O’Mahony (2012) makes two main points. The
first of these relates to the number of alternatives explored during
our assessment of colorectal cancer screening in Ireland (Sharp
et al, 2012), and the second relates to the terminology used in the
paper.
Our paper reports findings from a health technology assessment
(HTA) of colorectal cancer screening; the full report has been
published (Health Information and Quality Authority, 2009a). The
purpose of HTA is to inform decision makers about the relative
efficacy and costs of possible health-care interventions in order
that coherent policy decisions can be taken. In the case of our
work, the question of interest was whether population screening
for colorectal cancer in Ireland would be effective and cost effective.
History
Publication
British Journal of Cancer;108, pp. 1211-1212
Publisher
Nature Publishing Group
Note
peer-reviewed
Rights
First published in British Journal of Cancer, 2013, 108, pp. 1211-1212, http://dx.doi.org/doi: 10.1038/bjc.2012.491